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Abstract
Synaptic function is affected in many brain diseases and disorders. Technologies for large-scale
synapse assays can facilitate identification of drug leads. Here we report a “synapse microarray”
technology that enables ultra-sensitive, high-throughput, and quantitative screening of
synaptogenesis. Our platform enables the induction of synaptic structures in regular arrays by
precise positioning of non-neuronal cells expressing synaptic proteins, while allowing neurites to
grow freely around these cells. The technology increases by tenfold the sensitivity of the
traditional assays, and simultaneously decreases the time required to capture synaptogenic events
by an order of magnitude. It is readily incorporated into multiwell formats compatible with
industrial high-throughput screening platforms. Using this technology, we screened a chemical
library and identified novel histone deacetylase inhibitors that improve neuroligin-1 induced
synaptogenesis via modulating class-I histone deacetylases. We also found a structure-activity
relationship for designing novel potent histone deacetylase inhibitors, which can be applied
towards development of new therapeutics.
Introduction
Synapses are asymmetric intercellular junctions between neurons, which are crucial for
transforming and transmitting signals 1. Many abnormalities in brain function have direct or
indirect effects on synaptic function or originate from synaptic dysfunction 2-6. Hence, many
therapeutic strategies for neurological diseases and disorders target synapses, and the
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tdevelopment of high-throughput technologies for genetic and chemical screening of synaptic
function is highly significant and necessary for both fundamental and therapeutic
investigations.
Synapse formation and plasticity involve successive and dynamic recruitment of pre- and
postsynaptic molecules 7-8-9. These processes are intricately regulated by the trans-synaptic
adhesion proteins connecting pre- and postsynaptic terminals 10-12. However, the
bidirectional nature of synaptic signaling and the presence of a multitude of trans-synaptic
signals make it complicated to separate direct effects from indirect effects on synapse
assembly 13, posing major challenges for the development of screening methods for many
diseases where specific synaptic proteins are affected. Addition of purified synaptic
adhesion proteins to primary neuron cultures is not suitable, because most synaptic proteins
require membrane anchoring and lateral interactions to function normally 14. To overcome
these limitations, neuron-fibroblast cocultures have been employed, and have proven to be
powerful tools for studying many aspects of synapse formation and function 15. In these
assays, primary neurons are cocultured with non-neuronal cells transfected with cDNA
encoding only the specific synaptic proteins of interest. This provides significant control
over the proteins involved in trans-synaptic signaling, and thus greatly reduces the
complexity in dissecting the trans-synaptic signaling. Neuronal responses to the presented
synaptic proteins can be measured using quantitative immunocytochemistry, fluorescence
microscopy, and image analysis tools 16. Such assays have been used to identify several
adhesion proteins that modulate the synaptic function at pre- or postsynaptic
terminals 15,17-22. Among these synaptic adhesion proteins, neuroligins (NLGs) and
neurexins (NRXs) are the most widely studied ones, and they have been shown to connect
pre- and postsynaptic neurons, mediate signaling across synapses, and modulate the
properties of synaptic function. In humans, alterations in genes encoding NLGs or NRXs
have recently been implicated in autism and other cognitive diseases 6. Thus, coculture
assays are promising tools for screens to discover synapse-organizing factors and molecules
or drugs that modulate synaptic function.
However, existing coculture assays are not conducive to high-throughput screening for
several reasons. Random distribution and occurrence of neuron-fibroblast interactions on
culture substrates make it difficult to identify and analyze large and consistent numbers of
synaptogenesis events. Fibroblast cells typically exhibit irregular morphologies or cluster
together, severely hindering automated analysis. In addition, spatial variations in the density
of randomly growing neurites on substrates create significant fluctuations in the
quantification of synaptogenic events induced when neurites contact fibroblast cells, thereby
reducing assay sensitivity. As a result, large numbers of cells are required in order to make
statistically significant measurements, and subtle effects can be lost within experimental
noise. Finally, densely packed neuronal somata near fibroblast cells may provide
neurotrophic or other factors affecting synapse formation, and could indirectly bias the
effects of presented synaptic proteins 23.
To overcome these challenges, we developed an unprecedentedly sensitive and scalable
synapse assay technology that is also suitable for large-scale high-throughput screening
purposes using both chemical and protein expression libraries. This synapse microarray
technology overcomes the problems associated with the traditional coculture assays. It
enables the induction of synaptic structures at pre-determined positions inside precisely
controlled arrays of microwells, dramatically decreasing the time needed to capture
synaptogenic events by approximately an order of magnitude, which is crucial for
performing large-scale screens. Importantly, our technology also increases by tenfold the
sensitivity of traditional coculture assays: We demonstrate that the synapse microarrays can
detect synaptic changes induced by chemicals at ten-fold lower concentrations. Such
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timprovements in assay sensitivity, efficiency, and repeatability are crucial for detection of
subtle abnormalities in synaptic function, which are often associated with many severe brain
disorders 3-6. The platform also allows the use of minimal numbers of primary neurons and
amounts of reagents in large-scale screens. Using this technology, we screened a chemical
library at various concentrations. We identified novel histone deacetylase (HDAC) inhibitors
that promote synapse formation through neuroligin-1 (NLG1). Many chemicals had subtle
differential effects on synaptogenesis which we quantified by using synapse microarrays:
Through analysis of the relationship between synaptogenic activity and the variations in
chemical structures, we found a structure-activity relationship for designing novel potent
HDAC inhibitors. In combination with a biochemical deacetylase assay using recombinant
HDACs, we also showed that inhibition of class-I HDACs plays an important role in NLG1-
induced synaptogenesis.
Results
Design of the synapse microarray
Previously, chemically patterned substrates 24-25, soluble gradients 26, physical structures
that guide or compartmentalize neurites 27-28 have been employed to improve the
organization of cultured neurons. Microfluidic platform has also been used to conduct on-
chip electrophysiology 29, and to manipulate synaptic functions 30. However, unlike the
synapse microarrays introduced here, none of these techniques induces synapses in precise
arrays for quantitative and high-throughput studies. The synapse microarrays consist of two
main compartments connected by parallel microchannels (325 μm long, 10 μm wide, 3 μm
high, Fig. 1), which have been previously shown to effectively isolate axons from neuronal
somata 27 (also see Supplementary Fig. S1). Dissociated neurons are plated and cultured in
compartment 1 (Fig. 1a). The neural processes emanating from the somata grow through the
microchannels and extend into compartment 2 (Fig. 1b), which is covered by a thin (80 μm)
polydimethyl siloxane (PDMS) membrane held 3 μm above the substrate by small posts (10
μm diameter), which provide space for axonal outgrowth. The membrane also contains an
array of through-holes (microwells with 30 μm diameter). After a dense axon network forms
in compartment 2, HEK293 cells genetically engineered to express specific synapse-
inducing transmembrane proteins are seeded into the microwells using a brief centrifugation.
During rinsing, the cells captured within the holes are protected from shear stress, while the
excess HEK293 cells are easily removed, leaving behind only the captured cells in the
microwells (Fig 1c). The resulting occupancy of the microarrays typically exceeds 90%, and
over 85% of the microwells contain one to three HEK293 cells (Supplementary Fig. S2).
Cells are then cocultured for 1-2 days to allow for induction of synaptic structures.
Synapse microarrays can be fabricated using conventional soft-lithography techniques as
illustrated in Fig. 1d. Large-scale screens require use of multiwell plates. Synapse
microarrays are also easily adaptable to multiwell-plate format because they do not require
complex fluidic inputs and outputs. The micropatterned PDMS membrane is simply
sandwiched between a standard glass coverslip and multiwell-formatted culture wells. Each
96-well plate can perform 32 complete assays, where each assay unit consists of 3 connected
wells. First, neuronal cells are loaded into well A by direct pipetting. The neurons then
passively flow into compartment 1 in well B, which is coated with cell-adhesion proteins. 7
days later, HEK293 cells are pipetted and seeded into compartment 2 of well B as described
above. Well C is used for liquid exchange (Fig. 1d and 1e, also see Supplementary Fig. S3).
This design is also easily adaptable to 24-well, 48-well, and 384-well format plates.
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tPrecise control of neuron-fibroblast cocultures
The synaptogenic activity in coculture assays is assessed by the fluorescence measurements
of the synaptic clustering colocalized with HEK293 cells. An initial step in the induction of
these clusters is the formation of contacts between the axons and NLG1-expressing HEK293
cells, which depends both on neurite distribution and on spreading of HEK293 cells.
As neurite density varies spatially, the number of synapses that form when neurites contact
HEK293 cells fluctuate accordingly. We first examined whether our synapse microarray
system improves the uniformity of neurite density within the microwell array. We measured
the distribution of total neurite lengths in randomly sampled regions (30 μm in diameter) of
a traditional coculture and compared it with those measured in microwells of synapse
microarrays (Fig. 2). In traditional cultures, neurite density varies dramatically due to
uneven growth of neurons (Fig. 2a). In particular, neurite density significantly depends on
the distance from the soma due to neurite branching 31, which is not controlled in traditional
cultures. In the synapse microarrays, the somata are separated from HEK293 cells in
microwells by a well-defined distance determined by the length of the microchannels. The
resulting neurite density within the microwells is significantly more uniform as compared to
traditional cultures (Fig. 2c, P < 0.01, n = 3, ANOVA test, Fig. 2b vs. Fig. 2d). The
coefficient of variation (CV) for neurite length distribution in the synapse microarray (0.24
± 0.02, mean ± s.e.m.) is nearly half that of the traditional culture (0.47 ± 0.04, mean ±
s.e.m.). HEK293 cells plated onto the microwell array therefore encounter a more uniform
neurite distribution than they would do in a traditional coculture assay.
In addition, in traditional coculture assays, the spreading area of HEK293 cells shows
significant variation (900 ± 306 μm2, mean ± s.d., Fig. 2e, f), which affect the quantification
of synaptic clusters formed on individual HEK293 cells (Supplementary Fig. S4). Although
the measurement of synaptic clustering can be normalized by the area of HEK293 cells,
estimating the area of irregularly shaped HEK293 cells is often done manually and thus
laborious. Hence, fluctuation in the area of HEK293 cells is another factor that leads to
further variation in the estimate of synaptogenic activity. The synapse microarray overcomes
this problem by confining the HEK293 cells within microwells. The synapse count does not
show dependency on the number of HEK cells in microwells (Supplementary Fig. S5), since
the contact area between the neurites and HEK293 cells on the substrate is determined by
the diameter of the microwells. The microwells both provide access for HEK293 cells to the
uniform neurite network beneath the PDMS membrane and also constrain the growth and
spread of HEK293 cells to a defined region (676 ± 88 μm2, mean ± s.d., Fig. 2g, h). This
confinement of HEK293 cells does not affect NLG1 protein expression levels
(Supplementary Fig. S6).
To quantify presynaptic specialization induced by NLG1-expressing HEK293 cells, we
immunostained for synapsin after coculturing HEK293 cells with dissociated neurons for 24
hours (Fig. 2i, j). In traditional cocultures, we quantified synapses by measuring the total
fluorescence of synapsin clusters within each manually outlined region covered by
individual HEK293 cells. Fig. 2k shows that synapsin clustering is quite heterogeneous
(coefficient of variation = 0.89 ± 0.08, mean ± s.e.m.), and is substantially weak (“inactive”)
for a large fraction (38 ± 2%) of the HEK293 cells. In the microarray system, synapses were
quantified by measuring the total synapsin fluorescence in each microwell. The synapse
distribution in the microarray (Fig. 2l, m) was significantly more homogeneous (coefficient
of variation = 0.55 ± 0.06, P < 0.01, one way ANOVA, n = 3), as shown in Fig. 2n. The
inactive proportion of sampled regions was also significantly less than that of traditional
cocultures (13 ± 1%). Additionally, the distribution of synapsin puncta size is not affected
by the synapse microarray in comparison to the traditional coculture method (Supplementary
Fig. S7).
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tSensitivity analysis of synapse microarray technology
To demonstrate the capability of our synapse microarray technology for capturing
synaptogenic events in the presence of exogenously added chemicals, we first quantified the
effects of a known HDAC inhibitor on NLG1-induced presynaptic specialization. HDAC
inhibitors have already been shown to facilitate the development and function of excitatory
synapse in vitro 32, and also to enhance memory-related behavior in rodent models 33-35. We
found that the HDAC inhibitor, trichostatin A (TSA), significantly enhanced NLG1's ability
to induce presynaptic clustering, as compared to non-treated samples (P < 0.001, Fig. 3a).
This enhancement was not due to changes in the NLG1 expression levels in HEK293 cells
after TSA treatment (Fig. 3b).
To characterize the synapse microarray's sensitivity for detecting changes in synaptogenesis,
we performed a dose-response assay to measure the effect of TSA on NLG1-induced
presynaptic specialization, and we compared these results to those produced by traditional
coculture assays (Fig. 3c). Although traditional coculture assays allows detection of TSA-
enhanced presynaptic clustering at 300 nM (P < 0.001), it fails to detect any effect at lower
concentrations (i.e., for 30 nM and 100 nM, P > 0.05). On the other hand, the data acquired
using our synapse microarray consistently showed a linear dose-response to TSA, and we
were able to detect a significant increase in NLG1-induced presynaptic clustering, even at
the lowest TSA dose tested (30 nM, P < 0.001), indicating almost 10-fold improvement in
sensitivity over traditional coculture assays.
Automated image acquisition and processing for screens
Image acquisition and analysis of traditional coculture assays are typically performed
manually, which is both labor-intensive and error-prone, especially for large-scale screening
of chemical or cDNA libraries of synaptic proteins 21. The synapse microarray, however, is
exceptionally conducive to automated imaging and analysis. We use a standard fluorescence
microscope equipped with an automated stage to scan and acquire images from three
fluorescent channels (corresponding to HA-NLG1, synapsin, and βIII-tubulin). Composite
images are then analyzed using custom-made software that identified microwells filled with
HEK293 cells, and recorded the fluorescence intensity profiles of the different channels for
statistical analysis (Supplementary Movie 1). Thus, our synapse microarrays enable full
automation of both data acquisition and image analysis without any manual intervention or
special equipment. Table I shows that our platform is faster approximately by an order of
magnitude than the traditional coculture assay even when larger number of data points are
acquired by our platform. Such speed-up is crucial for conducting large-scale screens (see
discussion section).
Screening of chemical libraries using synapse microarrays
Inhibitors of general HDACs have been shown to enhance synapse development and
function 32,34. Yet, little is known about the mechanism connecting specific HDACs and
their involvement in neuroregenerative activities and synaptogenesis. Identification of which
subclasses of HDACs are important for synaptic function and discovery of selective
inhibitors of these specific HDACs is highly desirable for therapeutic purposes. Akhtar and
colleagues recently showed that HDAC1 and HDAC2 are key regulators of
synaptogenesis 32. To investigate whether HDACs are the relevant target for the
synaptogenic effect of TSA on NLG1 dependent signaling that we observed, and also to
identify novel HDAC inhibitors effective in promoting synapse formation, we next screened
a library of both known and novel HDAC inhibitors (Supplementary Table S1) comprising 3
additional chemotypes selected to provide information on the subclass of HDACs involved.
The novel HDAC inhibitors were initially selected after performing an in vitro biochemical
deacetylase assays using recombinant HDACs (Table 2), but their effects on synapse
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tformation in primary neurons were unknown a priori. Using the synapse microarrays, a total
of 22 compounds were screened in a blinded fashion at three concentrations (0.1, 1, 10 μM)
in duplicate (Fig. 4a, b). The chemicals we tested included SAHA, LBH-589, and scriptaid,
all of which are known potent hydroxamic-acid based HDAC inhibitors that are similar to
TSA and have IC50 values < 5 nM for class-I HDACs in our deacetylase assays (Table 2).
Consistent with the effects of TSA, all three of these HDAC inhibitors were also potent in
our coculture assay. In contrast, neither of the two compounds, valproic acid and
phenylbutyric acid, affected synaptogenesis at highest concentration (10 μM) tested, which
is consistent with their weak inhibition toward class-I HDACs in the deacetylase assay (IC50
> 40 μM) (Fig. 4c).
Since these hydroxamates and TSA are known to inhibit both class-I and class-IIb
HDACs 36-37, we also tested non-hydroxamates that show improved selectivity for class-I
HDACs (HDAC1/2/3/8). MS-275 is a benzamide class of HDAC inhibitor, which was
moderately potent toward only the class-I HDAC1/2/3 in our deacetylase assay (Table 2).
This compound showed moderate potency in the coculture assay at the highest concentration
tested (10 μM), causing ~1.5-fold increase in presynaptic clustering, compared to the
DMSO control. To extend these results to another structural class of non-hydroxamates, we
also tested apicidin, a natural product and one of the most potent class-I selective HDAC
inhibitors tested in our deacetylase assay (Table 2). As expected, this compound showed
greater potency than MS-275 in the coculture assay (Fig. 4c). Taken together, the results of
MS-275 and apicidin suggest that the class-I HDACs plays an important role in
synaptogenesis induced by NLG1.
To demonstrate the capability of our platform to identify novel molecules that can modulate
synaptogenesis, we also included in the chemical library 15 novel HDAC inhibitors based
upon hydrazone coupling chemistry 38. While all of these novel compounds showed strong
inhibition of the class-I HDAC1-3 in our deacetylase assays (Table 2), only some of them
enhanced NLG1-induced synaptogenesis (Fig. 4c). Like TSA, these novel HDAC inhibitors
all possess a hydroxamic acid, but have varying linker lengths and capping groups that differ
from TSA (Fig. 4a, b). The capping group and linker region have been modified extensively
towards the creation of class-selective or isoform-selective HDAC inhibitors 37,39. For
example, CN1 to CN2 differ by the number of the methylene groups in the linker region
between the hydroxamate and hydrazone moieties: CN1 has a 4 methylene linker whereas
CN2 has a 6 methylene linker. While both were potent HDAC inhibitors in the deacetylase
assays, CN2 was more potent than CN1 (Table 2). CN2 was also more potent than CN1 in
the coculture assays (Fig. 4c), which correlates with its increased HDAC inhibitory potency
over CN1. A similar structure-activity relationship existed between other novel
hydroxamate-containing compound pairs we have tested containing 4 vs. 6 methylene
linkers (i.e. CN3 & CN4, CN5 & CN6, CN7 & CN8).
In contrast to these correlations between the deacetylase assays and coculture assays, CN9,
CN10, CN11, and CN12 were potent class-I HDAC inhibitors but none were active in the
coculture assays. This indicates that in vitro biochemical assay on recombinant HDACs is
necessary but not sufficient for observing an effect of compounds on synaptogenesis,
highlighting the importance of cell-based assays for selecting useful modulators of HDAC-
mediated processes.
Of the novel compounds we screened, CN13, here named synapsinostat, was found to be the
most potent in promoting synaptogenesis, and it was effective even at the medium
concentration (1μM) tested. Synapsinostat (CN13) contains only a 5 carbon methylene
linker, similar to CN14 and CN15. CN14 was also a strong inducer of synaptogenesis but
only at higher concentrations (10 μM) while CN15 was inactive. CN14 and CN15 differ
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tfrom synapsinostat (CN13) by their capping elements. This demonstrates the importance of
the capping element for synaptogenic activity of the hydroxamic acid containing
compounds. Taken together, screening a collection of HDAC inhibitors at different
concentrations using synapse microarrays has provided insight for future synthetic chemistry
efforts aiming to develop selective regulators of synaptogenesis.
Discussion
We have demonstrated an array-based coculture system for conducting synaptogenesis
assays with unprecedented sensitivity and throughput over traditional assays. Synapse
microarrays enable the induction of synaptic structures at pre-determined locations in
regular arrays and eliminate several factors that cause fluctuations in the traditional
coculture assays. The high-throughput capability of the synapse microarray is crucial for
conducting large-scale screens, allowing the acquisition and analysis of large amounts of
data within a reasonable time scale. For example, performing a screen using traditional
coculture assays involving a medium size library of 100,000 chemicals would require
several years if done with existing methods; while the time could be reduced to a few
months if the screen is conducted using the synapse microarrays (Table 1). Furthermore, the
high sensitivity of the platform could enable the detection of subtle abnormalities in synaptic
function associated with complex brain disorders 4-6, which is a significant challenge for
pharmaceutical screens. In addition, the higher sensitivity of synapse microarrays enables
screening at significantly lower chemical concentrations, which is important for large-scale
screens due to the substantial reagent costs, and because many compounds have off-target or
toxic effects at higher doses 40. The higher sensitivity and the small configuration of assays
also allow use of minimal numbers of primary neurons, which are otherwise hard to obtain.
Using this synapse microarray technology, we screened a chemical library of novel HDAC
inhibitors, and identified chemicals, including synapsinostat (CN13), that promote synapse
formation through NLG1. Many chemicals had subtle differential effects on synaptogenesis
which we quantified by using synapse microarrays. Through analysis of the relationship
between synaptogenic activity and the chemical structures, we found a structure-activity
relationship for designing potent hydroxamate-containing HDAC inhibitors. We showed that
the length of the methylene linker between the metal chelating moiety of the hydroxamic
acid and capping element that extends toward the surface of the binding pocket plays a key
role in synaptogenic activity. In combination with in vitro biochemical deacetylase assays
using recombinant HDACs, we also found that inhibition of class-I HDACs plays an
important role in the process of NLG1-induced synaptogenesis. These results are consistent
with the previous findings of Akhtar et al 32, and further extend their findings by
demonstrating that neuroligin-1 is involved in mediating the effects of class-I HDAC
inhibitors. There is accumulating evidence that HDACs inhibitors exhibit neuroprotective
and neuroregenerative properties in cell culture and in animal models of various brain
diseases 41. Treatment with various HDAC inhibitors has emerged as a promising new
strategy for intervention in neurodegenerative diseases. However, most of the HDAC
inhibitors that have been tested in the context of neurological diseases are pan-HDAC
inhibitors i.e. targeting HDACs non-selectively 42. Prolonged broad-spectrum HDAC
inhibition using such pan-HDAC inhibitors can be problematic, because these inhibitors
have been associated with adverse side effects 43, and different HDACs likely serve distinct
regulatory functions within the adult brain 42,44. Hence, screening and discovery of novel
HDAC inhibitors is important for potential therapeutic applications, which can be achieved
using the synapse microarray technology.
With appropriate staining to subtype-specific synaptic markers (e.g. vGlut1 and GAD65),
the synapse microarray can be used to monitor differential effects of the small molecules on
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texcitatory versus inhibitory synapses (Supplementary Fig. S8). While the assays in our study
targeted the NLG1 pathway, other synaptic proteins aside from NLG1 can also be used in
chemical or RNAi screens. Similarly, using pools of HEK293 cells that are transected with
cDNA encoding different synaptic proteins, the synapse microarrays can also be used to
screen a library of candidate synapse inducing proteins, as recently demonstrated by Linhoff
and colleagues using traditional cocultures 21. With little modification, the synapse
microarrays can be easily adapted to study dendritic and postsynaptic development
(Supplementary Fig. S9), as well as to study various interactions among subtypes of
neurons, or between neurons and other types of cells in the nervous system, such as
astrocytes and oligodendrocytes.
Methods
Synapse Microarray Fabrication
The synapse microarray was made by assembling a standard coverslip, a micropatterned
PDMS membrane and multiwell-formatted culture wells. The PDMS membrane was replica-
molded from molds fabricated by soft lithography 45. The molds consisted of three
permanent SU-8 (Microchem) layers on a 4-inch silicon wafer. The first layer of SU-8 (3
μm in height) contained negative features for the supporting posts (in compartment 2) and
the microchannels for neurite growth. The second layer of SU-8 (40 μm in height) contained
negative features for the culturing channel in compartment 1. The third layer of SU-8 (80
μm in height) contained negative features for the microwells in compartment 2. All three
layers were patterned sequentially by photolithography using a 20,000 dpi printed
transparency mask (CAD Art Services, Inc.). To create the micropatterned PDMS
membrane, PDMS prepolymer was poured onto the mold and a plastic transparency was
then carefully lowered onto the prepolymer. The mold/prepolymer/transparency stack was
then clamped by two flat metal (aluminum) plates, on which high pressure was applied to
squeeze out extra prepolymer 46. The whole setup was baked at 85 °C for 12 hours before
releasing the patterned PDMS membrane (80 μm thick) from the mold.
Cell Culture
Hippocampal neuron cultures were prepared following the method previously described 47.
Briefly, dissociated neurons were prepared from hippocampi dissected from E18 Sprague
Dawley rats (Charles River) by enzymatic treatment with papain (Sigma) for 30 min at 37°C
followed by trituration with a 1 mL pipette tip. Before seeding neurons, all substrates were
pre-coated with polylysine (Sigma, 100 μg/ml) and laminin (Invitrogen, 10 μg/ml). To
characterize the synapse microarrays, we set up traditional and synapse microarray assays
side by side, and compared them quantitatively. For the traditional neuron-fibroblast
coculture assays, neurons were seeded onto 12 mm diameter coverslips at a density of 5 ×
104/cm2. For assays using the synapse microarrays, 10 μl of the cell solution (at a cell
density of 3 × 106/ml) was added to the cell loading wells to achieve a cell density similar to
that on the coverslips. This density yielded a uniform distribution of neurons in
compartment 1. Neuron cultures were maintained in Neurobasal (Invitrogen) medium
supplemented with B27, 0.5 mM L-glutamine, and antibiotics for 7 days before coculture
with HEK293 cells. Half the medium was replaced every 3-4 days.
The coculture of HEK293 cells and neurons were performed essentially as previously
described 16. HEK293 cells were cultured according to standard procedures. The N-terminal
HA-tagged murine NLG1 construct and the negative control construct, HA-tagged
acetylcholinesterase (AChE) were generous gifts from Prof. Peter Scheiffele. HEK293 cells
were transfected with the constructs using Lipofectamine (Invitrogen) and maintained in
DMEM medium containing 10% fetal bovine serum and geneticin (G418, Invitrogen). The
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ttransfected cells were trypsinized and collected as a cell suspension (1 × 105/ml). For
traditional coculture assays, HEK293 cells were seeded at a density of 2 × 104/cm2. For
assays using synapse microarrays, 100 μl of the HEK293 cell suspension was added to each
assay unit. The plate was centrifuged briefly at 100 g to allow the HEK293 cells to settle
into the microwells, and extra cells were rinsed away via medium exchange. The cocultures
were maintained in Neurobasal medium for 24-48 hours with addition of appropriate
chemicals at various concentrations. In all assays, chemicals were added to both cell body
and axon compartments of the synapse microarrays.
Immunocytochemistry
For analysis, cocultures were fixed for 30 min in 4% paraformaldehyde in phosphate-
buffered saline (PBS), permeablized in 0.25% Triton X-100 for 20 min, and then blocked
with 4% BSA in PBS for 2 hours at room temperature or overnight at 4 °C. Cultures were
incubated with primary antibodies in 4% BSA for 2 hours at room temperature, rinsed with
PBS, incubated with secondary antibodies for 1 hour, and were again rinsed with PBS
before imaging. Primary antibodies included chicken anti-HA (Millipore), rabbit anti-
synapsin (Millipore), mouse anti-βIII-tubulin (R&D), mouse anti-Tau1 (Millipore), rabbit
anti-MAP2 (Millipore), mouse anti-vGlut1 (Millipore) and rabbit anti-GAD65 (Millipore).
Image Acquisition and Quantification
Stained samples were imaged on a Nikon Eclipse TE2000 microscope equipped with a
motorized stage, cooled CCD camera and a 20x objective (0.75 NA). For quantification, all
samples within one experiment were stained simultaneously and imaged with identical
settings. For assays using the synapse microarrays, 10-15 images of the microwell area were
taken within 500 μm distance from the microchannels guiding neurites. For traditional
coculture assays, 10-15 images were taken at random positions on the substrate. All imaging
and analysis were performed blindly to the synapsin channel.
To quantify synapsin fluorescence, all synapsin fluorescent images within one experiment
were thresholded equally. For the traditional coculture assays, contours of the transfected
HEK293 cells (visualized by the HA-NLG1 fluorescent images) were manually outlined and
chosen as the regions of interest (ROIs). For assays using synapse microarrays, the
microwells filled with HEK293 cells were automatically selected as ROIs. Fluorescence
intensity in ROIs for both synapsin and HA tag were quantified and normalized to the
negative control using AChE-transfected HEK293 cells included in each experiment. The
analysis procedures for assays using microarrays were automated using a custom Matlab
script.
To quantify the total neurite length within each microwell (for assays using microarrays) or
within randomly sampled 30 μm diameter regions (for traditional coculture assays), the βIII-
tubulin fluorescence images were thresholded equally, and then skeletonized for
measurement of total neurite length, which was further normalized to the mean value in
order to visualize and quantify the dispersion and the distribution of the data.
Screening of Compounds Affecting Synaptogenesis
TSA, SAHA, LBH-589, scriptaid, MS-275, apicidin valproic acid, and phenylbutyric acid
were purchased from commercial vendors. All novel compounds (CN1-15) were made
following our published protocol 48. The purity of the novel compounds were determined by
analytical liquid chromatopgraphy-mass spectrometry (LC/MS) using a Waters 2545 High-
Performance Liquid Chromatography (HPLC) equipped with a 2998 diode array detector, a
Waters 3100 eESIMS module, using a XTerraMS C18 5 μm, 4.6×50 mm HPLC column at a
flow rate of 5 mL/min with a linear gradient (95% A: 5% B to 100% B 90 sec and 30 sec
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thold at 100% B, solvent A = water + 0.1% formic acid, solvent B = acetonitrile + 0.1%
formic acid, see Supplementary Fig. S10). Compounds were added to the synapse
microarray by replacing culture medium containing appropriate concentrations of each
compound. A compound is considered “active” if it induces an at least 1.5-fold increase in
total synapsin intensity over DMSO control level at tested concentrations (0.1, 1, 10 μM).
HDAC Biochemical Deacetylase Assays
Recombinant HDAC1, HDAC2, HDAC3, HDAC5, HDAC6, and HDAC8 were purchased
from BPS Biosciences. Assays of recombinant HDAC deacetylase activity were performed
with class-specific synthetic peptide substrates as described by Bradner et al 36.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic of the synapse microarray technology. (a) Neuronal cells are loaded and cultured
in compartment (cmpt) 1. (b) Neurites extend through the microchannels (325 μm long, 10
μm wide) and form a dense network in cmpt 2. Cmpt 2 is covered by a layer of 80 μm thick
PDMS membrane containing 30 μm diameter through-holes (see inset in (a)). The
membrane is held 3 μm above the substrate via dispersed 10 μm diameter posts (see inset in
(a)). (c) HEK293 cells expressing neuroligin-1 (NLG1 in inset) are then seeded into the
through-holes, and cocultured with neurons for 1-2 days in the presence of screening factors
prior to immunostaining for synaptic markers. NRX represents neurexin. (d) Fabrication of
the synapse microarray. Polydimethylsiloxane (PDMS) prepolymer is poured onto a mold
made from photoresist (SU-8) patterned on a silicon (Si) wafer. A plastic transparency is
lowered onto the prepolymer. The mold/prepolymer/transparency stack is then clamped by
two flat metal blocks, on which high pressure is applied to squeeze out extra prepolymer. A
micropatterned PDMS membrane is released from the wafer after curing PDMS, and then
sandwiched between a glass coverslip and multiwell-formatted culture wells to form the
synapse microarrays. Each assay unit consists of 3 connected wells (also see Supplementary
Fig. S3). (e) A photograph of the synapse microarray in multiwell format.
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Precise control of neuron-fibroblast coculture by synapse microarrays. (a) A representative
βIII-tubulin fluorescence image of neurites in traditional dissociated neuron culture. (b)
Distribution of total neurite length (normalized to mean) in randomly sampled regions of 30
μm diameter in a traditional culture (n = 247). (c) βIII-tubulin fluorescence image of
neurites in the synapse microarray. The microwells are circled in red, scale bar = 100 μm.
(d) Distribution of total neurite length (normalized to mean) in microwells within 500 μm
distance from the end of the microchannels guiding neurites (n = 270). (e) HEK293 cells
spread in varying morphologies in traditional cultures (staining for HA-NLG1). (f)
Histogram of HEK293 cell area in traditional cultures (n = 222). (g) HEK293 cells grow in
well-defined morphologies in the synapse microarray (staining for HA-NLG1), scale bar =
100 μm. (h) Histogram of HEK293 cell area in the synapse microarray (n = 286). (i)
Fluorescence image of synapsin clustering associated with NLG1-transfected HEK293 cells
(outlined in white) in traditional cocultures. (j) Enlarged view of the boxed region in panel
(i) (synapsin, red; HA-NLG1, green). (k) Histogram showing the distribution of synapsin
fluorescence intensity colocalized with HEK293 cells in traditional cocultures (n = 160). (l)
Fluorescence image of synapsin clustering in microwells (white circles) filled with HEK293
cells, scale bar = 100 μm. (m) Enlarged view of the boxed region in panel (l) (synapsin, red;
HA-NLG1, green), scale bar = 30 μm. (n) Histogram showing the distribution of synapsin
fluorescence intensity in microwells (n = 248). In panel (k) and (n), light gray covered
columns indicate the proportion of regions with substantially low synapsin fluorescence.
One standard deviation from the mean values (solid lines) is indicated by the dashed lines.
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Sensitivity analysis of the synapse microarray technology. (a) Effects of TSA on NLG1
induced synapsin clustering detected by synapse microarrays. *P < 0.001 by ANOVA
analysis. (b) Fluorescence intensities for HA-NLG1 or HA-AChE showing NLG1
expression levels in HEK293 cells under each condition examined. For panel (a) and (b),
error bars indicate s.e.m from 4 independent experiments. For each experiment, 200
microwells were analyzed for each condition, and the fluorescence intensities were
normalized to the control using AChE-transfected HEK293 cells. (c) Detection of TSA's
effects on NLG1 induced presynaptic clustering as a function of TSA concentrations. Box
plots of synapsin fluorescence intensities from assays using either the synapse microarray
(gray columns) or traditional coculture (white columns). The whiskers and elements of the
boxes correspond to 5, 25, 50, 75, and 95 percentiles of the data, whereas the diamond
corresponds to the dataset mean. Each box contains differing numbers of events collected
from equal number of images. Statistical significance was determined by Kruskal-Wallis
analysis.
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tFigure 4.
Screening of known and novel HDAC inhibitors for small molecules modulating
neuroligin-1 induced synaptogenesis using synapse microarrays. (a) 4 structural classes
(hydroxamic acids, benzamides, ketones, and carboxylic acids) of known HDAC inhibitors
are tested. (b) Novel hydroxamic acid containing HDAC inhibitors with varying linker
lengths and capping elements. (c) Fold increase in total synapsin intensity upon treatment of
cultures with the indicated compounds at 3 different concentrations (0.1 μM, blue; 1 μM,
red; 10 μM, green). A compound is considered “active” if it induces an at least 1.5-fold
increase in total synapsin intensity over DMSO control level at tested concentrations. While
a number of novel hydroxamic acid containing compounds increased synaptogenesis at 10
μM concentration, only CN13 (synapsinostat) is active at 1 μM.
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Table 1
Comparison of approximate times needed to analyze one sample for assays using synapse microarray vs.
traditional coculture.
Synapse microarray Traditional coculture
Number of Images 10 10
*Number of data points > 200 < 80
Image acquisition 100 s 250 s
Outline †ROI 20 s 1000 s
Data analysis 80 s 250 s
Total time 200 s 1500 s
*
Each data point corresponds to one microwell for assays using synapse microarrays, or one HEK293 cells for assays using traditional coculture.
†
ROI, region of interest
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